Shares of Medical Cannabis-Related Evogene Slightly Up On First Quarter Earnings
Computational biology company Evogene Ltd. (NASDAQ: EVGN) reported Wednesday its first-quarter financial results with revenue of $333,000, compared to $75,000 in the same period of 2020.
